Already have an ACS ID? Log in
Renew your membership, and continue to enjoy these benefits.
Already an ACS Member? Log in here
Choose the membership that is right for you. Discount will be applied automatically at checkout.
Enjoy these benefits no matter which membership you pick.
Most Popular in Business
ShangPharma, a Shanghai-based contract research organization (CRO) whose subsidiary, Shanghai ChemExplorer, has a major contract with Eli Lilly & Co., has received a $30 million investment from the investor group TPG. ShangPharma, which claims to be China's leading CRO, says it plans to expand in the areas of assay development, compound screening, and drug metabolism and pharmacokinetic studies. It also plans to establish a current Good Manufacturing Practices-certified manufacturing facility.
This article has been sent to the following recipient: